Literature DB >> 26580581

Rare Presentation of Lupus Myocarditis With Acute Heart Failure-A Case Report.

Gurveen Malhotra1, Serafin Chua, Vamsi Kodumuri, Sivashankar Sivaraman, Priya Ramdass.   

Abstract

Systemic lupus erythematosus is an autoimmune disease with diffuse organ involvement. The cardiac complications include pericarditis, myocarditis, pulmonary hypertension, coronary vasculitis, and Libman-Sacks endocarditis. Symptomatic lupus myocarditis presenting with left ventricular dysfunction, acute heart failure, and pulmonary edema, although rare, is a life-threatening complication. We report the occurrence of acute lupus myocarditis in a 38-year-old postpartum female who had a cesarean section a week before presentation for preeclampsia. Initially she was managed for pneumonia but later found to have acute pericarditis and myocarditis related to systemic lupus erythematosus. She had a complicated hospital course including acute respiratory failure and cardiogenic shock. She was started on pulse dose steroids besides the treatment for heart failure and had a dramatic improvement within days.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26580581     DOI: 10.1097/MJT.0000000000000295

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  3 in total

1.  Mycophenolate Mofetil Use in Severe Myocarditis Complicating Systemic Lupus.

Authors:  Abire Allaoui; Amal El Ouarradi; Rajaa Jabbouri; Abdelhamid Naitelhou
Journal:  Cureus       Date:  2022-06-09

Review 2.  The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock.

Authors:  Maya Guglin; Carson Smith; Roopa Rao
Journal:  Heart Fail Rev       Date:  2020-11-19       Impact factor: 4.214

Review 3.  Cardiogenic shock in autoimmune rheumatologic diseases: an insight on etiologies, management, and treatment outcomes.

Authors:  Ayman Battisha; Khalid Sawalha; Ahmed M Altibi; Bader Madoukh; Mohammad Al-Akchar; Brijesh Patel
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.